Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
about
Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infectionExpression of HIV-1 antigens in plants as potential subunit vaccinesImmunogenicity of viral vector, prime-boost SIV vaccine regimens in infant rhesus macaques: attenuated vesicular stomatitis virus (VSV) and modified vaccinia Ankara (MVA) recombinant SIV vaccines compared to live-attenuated SIV.Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.HIV-1-specific antibody responses during acute and chronic HIV-1 infectionProgression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment.Interlaboratory variability of CD8 subset measurements by flow cytometry and its applications to multicenter clinical trials. NAID/NICHD Women and Infants Transmission Study GroupIsotype Diversification of IgG Antibodies to HIV Gag Proteins as a Therapeutic Vaccination Strategy for HIV Infection.Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1T cell independent secondary antibody responses to the envelope protein of simian immunodeficiency virusHIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.Markers predicting progression of human immunodeficiency virus-related disease.Hybrid human immunodeficiency virus Gag particles as an antigen carrier system: induction of cytotoxic T-cell and humoral responses by a Gag:V3 fusion.E. coli Heat-labile Enterotoxin B Subunit as a Platform for the Delivery of HIV Gag p24 Antigen.Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infectionCurrent status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).Hybrid Ty virus-like particles.Can HIV p24 be a suitable scaffold for presenting Env antigens?
P2860
Q24645815-EEE0C802-6A1D-4A40-9931-3D165DF02B7EQ33345905-3B1B47EF-505F-419F-BC14-B84041B2361CQ33653655-15D1FE13-AC91-45DB-A21F-EAC5AF84F4F4Q33783960-A11E4C67-F2BF-48BB-8622-272E79E05071Q33827771-E966CCAD-2847-4959-B0FF-7CA44D7E24DBQ35096836-17F558D5-42FA-4F3C-A6DF-8A75770E61C5Q35181236-15704617-7094-4BDC-938B-64AA0361A478Q35224739-FA787049-B60A-42CE-9314-31C3880D40CAQ35826668-E315196B-1D97-477A-ABDA-E8302B7FDE4CQ35880498-7343D94D-9722-482A-8DB5-4BC51DE80E9CQ36127805-25093905-CB60-4888-ADC1-C5F2B9AF18BFQ36401419-293F16A3-FD36-4BE5-8082-B8FD273CFC11Q36640801-E3E049D7-4CD6-4E2B-A775-5EFE5610A60CQ36647277-57B83D5E-9D8F-40F7-84C9-DC3C5ED90A91Q37058225-388A50CD-2D0D-4EF4-8456-2386EECB339BQ37295135-DA7BE18C-0C78-4D34-BF89-739ACF056832Q37967232-0072AEB5-F74C-4514-962E-2C15E568B20BQ40680966-100139F3-E5FC-4C51-B2EA-384A84FDE9E5Q42959395-7FCBF572-31D6-431C-801C-604E32FE62B9
P2860
Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Relation between humoral respo ...... ical outcome of HIV infection.
@en
type
label
Relation between humoral respo ...... ical outcome of HIV infection.
@en
prefLabel
Relation between humoral respo ...... ical outcome of HIV infection.
@en
P2093
P2860
P356
P1433
P1476
Relation between humoral respo ...... ical outcome of HIV infection.
@en
P2093
Aronstam A
Cheingsong-Popov R
Panagiotidi C
Wadsworth J
P2860
P356
10.1136/BMJ.302.6767.23
P407
P577
1991-01-01T00:00:00Z